Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Rigel Pharmaceuticals (NQ: RIGL )

0.9317 +0.0217 (+2.38%)
Streaming Delayed Price Updated: 12:46 PM EDT, May 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Rigel Pharmaceuticals

< Previous 1 2 3 4 Next >
Why Are Chinese Stocks BABA, BILI, IQ Up Today?
Chinese stocks are climbing higher on Friday as investors continue to hope that the country will ease off of Covid-19 restrictions. 
Via InvestorPlace
BBWI Stock Climbs as Bath & Body Works Candle Day Sale Kicks Off
Bath & Body Works (BBWI) stock is rising higher on Friday as the retail company starts its annual Candle Day sale with a deep discount. 
Via InvestorPlace
Gold Down 1%; Samsara Shares Spike Higher
U.S. stocks traded lower midway through trading, with the Dow Jones falling around 75 points on Friday. 
Via Benzinga
Rigel Pharmaceuticals (RIGL) Stock Soars on FDA Approval News
Rigel Pharmaceuticals (RIGL) stock is heading higher on Friday after getting approval from the FDA for its leukemia treatment. 
Via InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Another Clinical Trial Setback For Rigel Pharma's Lead Program, This Time For COVID-19
Via Benzinga
Expert Ratings for Rigel Pharmaceuticals
  Rigel Pharmaceuticals (NASDAQ:RIGL) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Why UiPath Shares Are Trading Higher By Around 8%; Here Are 24 Stocks Moving Premarket
Gainers 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
We're starting off the day with an overview of the biggest pre-market stock movers traders need to know about for Friday morning! 
Via InvestorPlace
Preview: Rigel Pharmaceuticals's Earnings
Rigel Pharmaceuticals (NASDAQ:RIGL) is set to give its latest quarterly earnings report on Thursday, 2022-11-03. Here's what investors need to know before the announcement. Analysts estimate that Rigel... 
Via Benzinga
Why Rogers Shares Are Trading Sharply Lower; Here Are 33 Stocks Moving Premarket
Gainers Avinger, Inc. (NASDAQ: AVGR) rose 32% to $1.36 in pre-market trading. Avinger is expected to release its financial results for the third quarter on Wednesday, November 9, 2022. 
Via Benzinga
Earnings Scheduled For November 3, 2022
Companies Reporting Before The Bell • Hyatt Hotels (NYSE:H) is estimated to report quarterly earnings at $0.28 per share on revenue of $1.45 billion. 
Via Benzinga
Why Laser Photonics Shares Jumped By Around 44%; Here Are 72 Biggest Movers From Yesterday
Gainers FedNat Holding Company (NASDAQ: FNHC) shares climbed 107.7% to close at $0.3395 on Tuesday. 
Via Benzinga
Nasdaq Drops 150 Points; AZZ Shares Plummet
U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite dropping around 150 points on Tuesday. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers 
Via Benzinga
Why ForgeRock Shares Are Trading Higher By Over 49%, Here Are 50 Stocks Moving In Tuesday's Mid-Day Session
Gainers FedNat Holding Company (NASDAQ: FNHC) shares jumped 140% to $0.3939. 
Via Benzinga
Dow Surges Over 100 Points; Crude Oil Down 2%
U.S. stocks pared some losses midway through trading, with the Dow Jones gaining more than 100 points on Tuesday. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers DICE Therapeutics (NASDAQ:DICE) stock moved upwards by 83.4% to $45.2 during Tuesday's pre-market session. The market value of their outstanding shares is at $1.7 billion. 
Via Benzinga
Rigel Pharma Drops FDA Submission Plans For Expanded Use Of Its Lead Product
Rigel Pharmaceuticals Inc (NASDAQ: RIGL) received guidance from the FDA's review of its re-analysis of data from the FORWARD Phase 3 trial of fostamatinib for warm autoimmune hemolytic anemia... 
Via Benzinga
Why Leggett & Platt Shares Are Trading Lower; Here Are 24 Stocks Moving Premarket
Gainers Vox Royalty Corp. (NASDAQ: VOXR) rose 60.4% to $4.33 in pre-market trading. Vox Royalty’s common shares commenced trading on The Nasdaq Stock Market on Monday. 
Via Benzinga
iQIYI, Las Vegas Sands And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Reshape Lifesciences (NASDAQ:RSLS) shares increased by 12.7% to $0.34 during Monday's after-market session. The market value of their outstanding shares is at $1.2 million. 
Via Benzinga
Why XPeng Shares Traded Lower By Around 11%; Here Are 77 Biggest Movers From Yesterday
Gainers 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
  
Via Benzinga
Piper Sandler Maintains Neutral Rating for Rigel Pharmaceuticals: Here's What You Need To Know
  Piper Sandler has decided to maintain its Neutral rating of Rigel Pharmaceuticals (NASDAQ:RIGL) and raise its price target from $1.00 to $2.00. Shares of Rigel Pharmaceuticals are trading up 1.12%... 
Via Benzinga
Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Rigel Pharma Expands Blood Cancer Portfolio With Forma Therapeutics Licensing Pact
Via Benzinga
Rigel Pharmaceuticals: Q2 Earnings Insights
Rigel Pharmaceuticals (NASDAQ:RIGL) reported its Q2 earnings results on Tuesday, August 2, 2022 at 04:01 PM. Here's what investors need to know about the announcement. 
Via Benzinga
Biotech Daily: Trial Setback For Eliem Therapeutics, Allarity Drops Work On Cancer Monotherapies, Axcella Aces Long COVID Study
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Earnings Scheduled For August 2, 2022
Companies Reporting Before The Bell • Ferrari (NYSE:RACE) is expected to report quarterly earnings at $1.27 per share on revenue of $1.22 billion. 
Via Benzinga
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.